ロード中...
COVID‐19 and the pulmonary complications of sickle cell disease
Sickle cell disease (SCD) patients are commonly affected by pulmonary complications such as acute chest syndrome (ACS), pulmonary embolism (PE) and pneumonia that contribute to significant mortality risks. With a greater susceptibility to infection, they are deemed to be vulnerable patients during t...
保存先:
| 出版年: | EJHaem |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7675298/ https://ncbi.nlm.nih.gov/pubmed/33230510 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jha2.105 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|